DIRECT DBS: A prospective, multi-center clinical trial with blinding for a directional DBS lead
Objective: DIRECT DBS is an exploratory study which will investigate the effects of subthalamic deep brain stimulation (DBS) using directional DBS leads with current steering…Whole body vibration therapy with exercise enhances motor function and improves quality of life in Parkinson’s disease
Objective: To evaluate the short term effects of whole body vibration and exercise in patients with Parkinson's disease on overall quality of life, gait, tremor,…Proprioceptive training as a means to enhance sensorimotor function in Parkinson’s disease
Objective: To identify whether proprioceptive function in Parkinson's disease (PD) can be enhanced by specialized visuomotor training that emphasizes precise movements and determine if such…Pallidal versus subthalamic stimulation for PD: Beyond the motor effects
Objective: To evaluate the effects of Deep Brain Stimulation(DBS) on non motor symptoms(NMS) in Parkinson's disease(PD) and compare the efficacy of pallidal(GPi) versus subthalamic(STN) stimulation.…Improved motor functioning of people with Parkinson’s disease following dance intervention
Objective: To investigate the effectiveness of dance as an additional treatment for people with Parkinson's disease (PD). Background: Common pharmacological treatments for PD lessen the…Auditory cues during obstacle crossing increase gait asymmetry in neurologically health individuals but not in people with Parkinson’s disease
Objective: To investigate the influence of auditory cue on gait asymmetry in an environment unobstructed and with obstacle in people with Parkinson's disease (PD) and…PARK-OMM – An osteopathic manipulative medicine protocol to improve motor function and balance in Parkinson’s disease
Objective: To evaluate the effects of a pre-defined Osteopathic Manipulative Medicine (OMM) treatment protocol (PARK-OMM) for 6 weeks compared to a 6-week controlled counseling period…Conversion of patients from immediate release carbidopa-levodopa (IR CD-LD) and sustained release carbidopa-levodopa (SR CD-LD) to extended-release carbidopa-levodopa (ER CD-LD) in clinical practice
Objective: To evaluate the real-world response of patients who are converted from IR CD-LD and SR CD-LD to ER CD-LD in an academic practice. Background:…Extended-release carbidopa-levodopa, IPX066: Dosing and efficacy with concomitant medication use in Parkinson’s disease
Objective: Evaluate the efficacy and dosing of IPX066 in patient groups taking concomitant Parkinson's disease (PD) medication, using post hoc subgroup analyses. Background: IPX066 is…Peripheral neuropathies in Parkinson’s disease during levodopa-carbidopa intestinal gel treatment: Results from a long-term prospective follow-up study
Objective: To prospectively evaluate, in a cohort of Parkinson's disease (PD) patients, the incidence of peripheral neuropathies (PNP) during Levodopa/Carbidopa intestinal gel (LCIG) treatment. Background:…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.